Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | PLK1 | P53350 | 3/20 | 0.34 |
| ▸ | PTPN11 | Q06124 | 6/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.32 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.32 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.31 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14816401 | 0.82 | MEN1 (0.34) | MEN1KMT2APTPN11PTPN1 | |
| SCHEMBL10710500 | 0.82 | MEN1 (0.48) | MEN1KMT2APOLBKDM4EALDH1A1 | |
| SCHEMBL8672468 | 0.81 | KMT2A (0.37) | MEN1KMT2APOLBRXFP1ALDH1A1 | |
| SCHEMBL1096403 | 0.80 | MEN1 (0.42) | MEN1KMT2APOLBRXFP1KDM4E | |
| SCHEMBL1095842 | 0.80 | ALOX5 (0.39) | PLK1POLBKDM4EALDH1A1HPGD | |
| SCHEMBL2524404 | 0.80 | ALOX5 (0.39) | PLK1POLBKDM4EALDH1A1HPGD | |
| SCHEMBL10708450 | 0.80 | KMT2A (0.43) | MEN1KMT2APOLBRXFP1 | |
| SCHEMBL7773647 | 0.79 | MEN1 (0.39) | MEN1KMT2APOLBRXFP1KDM4E | |
| SCHEMBL9323129 | 0.79 | MEN1 (0.45) | MEN1KMT2APOLBRXFP1 | |
| SCHEMBL11053579 | 0.78 | RXFP1 (0.43) | MEN1KMT2ARXFP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6806368-B2 | FOR ELECTRONIC, OPTOELECTRONIC AND PHOTONIC APPLICATIONS, FOR COLORATION OF MACROMOLECULAR ORGANIC AND OF INORGANIC MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-19 | — | — | US | disclosed |
| US-20030181721-A1 | Liquid crystalline 3,4:9,10-perylenetetacarbocylic acid diimides | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181721-A1 | Liquid crystalline 3,4:9,10-perylenetetacarbocylic acid diimides | CCR9, CLTA, HAO2 | MEN1 3390/4885KMT2A 3149/4885PLK1 3850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.